Blog

October 30, 2009

There is a great deal to analyze in the more than 1,900 pages that make up the proposed health reform legislation unveiled by House leaders this week, and we’ll be … Continued

October 29, 2009

Below is my blog post which was featured today on Disruptive Women In Health Care: If only it were an urban legend that senior citizens in the United States were … Continued

October 27, 2009

They’ve been called “immoral,” “skyrocketing” and “obscene,” but the fact is that health insurer profits don’t match the rhetoric coming from proponents of a government health plan option. Unfortunately, health … Continued

October 26, 2009

An upcoming edition of the British medical journal The Lancet will feature the results of research into a new diabetes drug that is demonstrating significant progress in helping obese patients … Continued

October 23, 2009

“Support for Public Option Grows In House and Senate”  Headline, Washington Post, October 23 “Pelosi Lacks Votes For Most Sweeping Public Option”  Headline, Politico, October 23

October 20, 2009

Advocates of a government-run health insurance plan are calling today’s published Washington Post/ABC News poll a game-changer, placing the impetus on Congress to give the public what it ostensibly wants.  … Continued

October 14, 2009

Hollywood movie producers love what are known as “high concept” film ideas.  These are plotlines that are so simple – “aliens invade Earth”, “teenage vampires take on mortals” – they … Continued

October 9, 2009

Opponents of medical liability reform have always been fond of quoting the Congressional Budget Office saying that reform measures would do very little to save taxpayers money and squeeze unnecessary … Continued

October 6, 2009

The superb New York Times columnist David Brooks has a piece in today’s newspaper that is well worth reading.  He raises one of the most important, and yet overlooked, questions … Continued

October 5, 2009

In a speech today at the Cleveland Clinic Innovation Summit, the CEO of one of the world’s leading pharmaceutical companies called for a stronger, adequately-funded Food and Drug Administration to … Continued